Division of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
J Exp Med. 2009 Dec 21;206(13):2879-88. doi: 10.1084/jem.20091750. Epub 2009 Dec 14.
Tuberculosis remains a fatal disease caused by Mycobacterium tuberculosis, which contains various unique components that affect the host immune system. Trehalose-6,6'-dimycolate (TDM; also called cord factor) is a mycobacterial cell wall glycolipid that is the most studied immunostimulatory component of M. tuberculosis. Despite five decades of research on TDM, its host receptor has not been clearly identified. Here, we demonstrate that macrophage inducible C-type lectin (Mincle) is an essential receptor for TDM. Heat-killed mycobacteria activated Mincle-expressing cells, but the activity was lost upon delipidation of the bacteria; analysis of the lipid extracts identified TDM as a Mincle ligand. TDM activated macrophages to produce inflammatory cytokines and nitric oxide, which are completely suppressed in Mincle-deficient macrophages. In vivo TDM administration induced a robust elevation of inflammatory cytokines in sera and characteristic lung inflammation, such as granuloma formation. However, no TDM-induced lung granuloma was formed in Mincle-deficient mice. Whole mycobacteria were able to activate macrophages even in MyD88-deficient background, but the activation was significantly diminished in Mincle/MyD88 double-deficient macrophages. These results demonstrate that Mincle is an essential receptor for the mycobacterial glycolipid, TDM.
结核分枝杆菌仍然是一种致命的疾病,它包含各种影响宿主免疫系统的独特成分。海藻糖-6,6'-二没食子酸酯 (TDM; 也称为 cord 因子) 是分枝杆菌细胞壁糖脂,是分枝杆菌最具研究价值的免疫刺激成分。尽管对 TDM 进行了五十年的研究,但它的宿主受体尚未明确确定。在这里,我们证明巨噬细胞诱导型 C 型凝集素 (Mincle) 是 TDM 的必需受体。热灭活分枝杆菌激活了表达 Mincle 的细胞,但细菌脱脂质后活性丧失;脂质提取物的分析确定 TDM 是 Mincle 的配体。TDM 激活巨噬细胞产生炎症细胞因子和一氧化氮,而 Mincle 缺陷型巨噬细胞则完全抑制这些物质的产生。体内 TDM 给药可诱导血清中炎症细胞因子的强烈升高,并引起特征性的肺部炎症,如肉芽肿形成。然而,在 Mincle 缺陷型小鼠中未形成 TDM 诱导的肺部肉芽肿。即使在 MyD88 缺陷型背景下,完整的分枝杆菌也能够激活巨噬细胞,但在 Mincle/MyD88 双缺陷型巨噬细胞中,这种激活显著减弱。这些结果表明 Mincle 是分枝杆菌糖脂 TDM 的必需受体。
J Exp Med. 2009-12-14
Mol Cell Proteomics. 2019-1-11
Vaccines (Basel). 2025-6-24
Adv Exp Med Biol. 2025
Infect Immun. 2025-7-8
Biomolecules. 2025-5-12
Virulence. 2025-12
Proc Natl Acad Sci U S A. 2025-5-20
J Exp Med. 2009-8-3
Proc Natl Acad Sci U S A. 2009-2-10
Nat Immunol. 2008-10
J Biol Chem. 2008-10-24
Curr Opin Infect Dis. 2008-6